Detalhe da pesquisa
1.
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 397(10290): 2169-2181, 2021 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023009
2.
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial.
JAMA Dermatol
; 159(6): 596-605, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074705
3.
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.
JAMA Dermatol
; 159(5): 526-535, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043227
4.
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Am J Clin Dermatol
; 23(3): 365-383, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567671